Unknown PHASE4 INTERVENTIONAL NCT00166842

Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients.

Sponsor: National Taiwan University Hospital

Conditions Immunosuppression Kidney Transplantation Transplantation

Interventions sirolimus, cyclosporine, tacrolimus

Updated 4 times since 2017 Last updated: Sep 12, 2005 Started: Sep 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Immunosuppression and Kidney Transplantation and is currently ongoing. National Taiwan University Hospital leads this study, which shows 4 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan